Second, numerous chemotherapies have been reported to upregulate the expression of PD-L1 on tumor or myeloid cells [86,92,93,94,95], which reduces treatment efficacy but paradoxically increases the target for ICIs that can impede this immunosuppressive effect. This evidence concerns the gene CD274 and neoplasm.